STOCK TITAN

Nu Skin Enter Stock Price, News & Analysis

NUS NYSE

Welcome to our dedicated page for Nu Skin Enter news (Ticker: NUS), a resource for investors and traders seeking the latest updates and insights on Nu Skin Enter stock.

Nu Skin Enterprises Inc (NYSE: NUS) provides a centralized hub for tracking corporate developments across its global health, beauty, and wellness operations. This resource aggregates official press releases and verified news updates related to product innovations, financial performance, and strategic initiatives.

Investors and stakeholders gain immediate access to essential updates including quarterly earnings disclosures, manufacturing advancements through subsidiaries like Groviv and Wasatch Labs, and expansions of the company’s direct-selling network. All content is curated to support informed analysis of Nu Skin’s market position in the beauty and nutraceutical sectors.

The news collection features developments across three key areas: product launches in skincare and nutritional supplements, sustainability initiatives in automated agriculture technology, and financial disclosures reflecting global operations in 50+ countries. Additional coverage includes leadership updates and partnership announcements with digital platforms like Mavely.

Bookmark this page for streamlined monitoring of Nu Skin’s progress in merging scientific research with direct-selling expertise. Regular updates ensure timely awareness of material developments affecting the company’s NYSE-listed performance.

Rhea-AI Summary
Nu Skin Enterprises (NUS) reported Q1 2025 revenue of $364.5 million, reaching the high end of guidance despite a 12.7% year-over-year decline. EPS was $2.14, or $0.23 excluding Mavely gain and other charges. The company saw growth in Latin America and Rhyz manufacturing but faced challenges in premium beauty due to inflation and tariffs. Key metrics showed declines with customers down 11%, paid affiliates down 15%, and sales leaders down 20%. The company reduced debt by $155 million, reaching its lowest level in 10 years. For Q2 2025, Nu Skin projects revenue of $355-390 million with EPS of $0.20-0.30. Full-year 2025 guidance maintained at $1.48-1.62 billion in revenue and EPS of $2.80-3.20 (or $0.90-1.30 excluding Mavely gain).
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
11.04%
Tags
none
-
Rhea-AI Summary

Nu Skin Enterprises (NYSE: NUS) has announced that its board of directors has declared a quarterly cash dividend of $0.06 per share. The dividend will be paid on June 11, 2025, to shareholders who are on record as of May 30, 2025. This dividend declaration represents the company's continued commitment to returning value to shareholders through regular dividend payments.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
11.04%
Tags
dividends
-
Rhea-AI Summary

Nu Skin Enterprises (NYSE: NUS) has scheduled the release of its first quarter 2025 financial results after market close on Thursday, May 8. The company's management team will host a conference call with investors at 5 p.m. ET on the same day to discuss quarterly performance and upcoming business initiatives.

The financial presentation and conference call will be accessible via webcast on the company's investor relations website at ir.nuskin.com. A replay option will remain available through Thursday, May 22.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.21%
Tags
Rhea-AI Summary

Nu Skin Enterprises (NYSE: NUS) reported Q4 2024 revenue of $445.6 million, down 8.8% year-over-year but above company guidance, with a 4.1% FX impact. Q4 EPS was $(0.73), or $0.38 excluding restructuring charges. Full-year 2024 revenue reached $1.73 billion, declining 12% with a 3.8% FX impact.

The company's Rhyz segment showed strong growth, with Q4 revenue of $83.1 million (+27.7%) and full-year revenue of $286.6 million (+32.3%). Customer base decreased 15% to 831,972, with paid affiliates down 13% and sales leaders declining 16%.

For 2025, Nu Skin projects revenue between $1.48-$1.62 billion, expecting a 3% FX headwind. Q1 2025 revenue guidance is $345-365 million, with EPS forecast of $2.65-$2.75, or $0.10-$0.20 excluding the Mavely transaction gain.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
17.76%
Tags
-
Rhea-AI Summary

Nu Skin Enterprises (NYSE: NUS) has announced that its board of directors has declared a quarterly cash dividend of $0.06 per share. The dividend will be paid on March 5, 2025, to shareholders of record as of February 24, 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
17.76%
Tags
dividends
-
Rhea-AI Summary

Nu Skin Enterprises (NYSE: NUS) has announced that its Q4 2024 preliminary revenue is at the high end of the company's guidance range. This announcement comes ahead of its presentation at the ICR Conference on Jan. 14, where President and CEO Ryan Napierski, along with CFO James Thomas, will discuss the company's strategy and performance, including the recent strategic acquisition of Mavely for $250 million. The presentation will be webcast live at 3 p.m. ET on the company's investor relations page, with an archive available through Jan. 28.

Nu Skin will release its full Q4 and full year 2024 financial results after market close on Feb. 13. Following the release, the management team will host a conference call at 5 p.m. ET, which will also be webcast live on the investor relations page. A replay will be accessible through Feb. 27.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.81%
Tags
none
Rhea-AI Summary

Nu Skin Enterprises (NYSE: NUS) announced that its subsidiary Rhyz Inc. has completed a strategic transaction with Later, selling its Mavely affiliate marketing technology platform for approximately $250 million in cash and a minority equity stake in the combined Later/Mavely business. Of this amount, $33 million will be distributed to other Mavely equity holders.

The transaction represents a five-times return on Nu Skin's investment since acquiring Mavely in 2021. Mavely will continue providing technology and social commerce capabilities to support Nu Skin's affiliate marketing business. The company plans to use the proceeds to reduce debt, fund innovation, and repurchase shares under its existing stock buyback program.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
14.79%
Tags
none
-
Rhea-AI Summary

Later, a leader in influencer marketing and social media management, has acquired Mavely for $250 million, funded by Summit Partners. The acquisition from Nu Skin Enterprises (NYSE:NUS) subsidiary Rhyz Inc enhances Later's capabilities in creator-driven marketing, combining Later's AI predictive analytics with Mavely's network of over 120,000 creators who have generated more than $1 billion in gross merchandising volume across 1,400+ major brands.

The merger aims to deliver full-funnel impact and measurable ROI for marketers while enabling creators to maximize earnings through social commerce. Mavely's leadership team, including CEO Evan Wray, CTO Sean O'Brien, and CFO Kevin Kenefick, will join Later's leadership team. The combined platform will focus on enhancing creator collaboration and helping marketers deliver measurable results with greater confidence.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
14.79%
Tags
-
Rhea-AI Summary

Nu Skin Enterprises (NYSE: NUS) reported Q3 2024 revenue of $430.1 million, down 13.8% year-over-year, with a 3.4% FX impact. The company's Rhyz segment showed strong growth of 20.9%, reaching $73.1 million. Earnings per share were $0.17 compared to $(0.74) in the prior year. Customer base declined 15% to 831,768, while paid affiliates decreased 20%. The company is implementing a revised business model and streamlined operating framework to improve profitability. For full-year 2024, Nu Skin adjusted its outlook to revenue between $1.70-$1.73 billion and EPS of $(2.32)-$(2.22), or $0.65-$0.75 non-GAAP.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.55%
Tags
Rhea-AI Summary

Nu Skin Enterprises (NYSE: NUS) has announced that its board of directors declared a quarterly cash dividend of $0.06 per share. The dividend will be paid on December 11, 2024, to shareholders of record as of November 29, 2024.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.55%
Tags
dividends

FAQ

What is the current stock price of Nu Skin Enter (NUS)?

The current stock price of Nu Skin Enter (NUS) is $7.44 as of May 12, 2025.

What is the market cap of Nu Skin Enter (NUS)?

The market cap of Nu Skin Enter (NUS) is approximately 292.5M.
Nu Skin Enter

NYSE:NUS

NUS Rankings

NUS Stock Data

292.52M
45.88M
3.41%
77.58%
4.4%
Household & Personal Products
Wholesale-drugs, Proprietaries & Druggists' Sundries
Link
United States
PROVO